BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Emani S, Burkhoff D, Lilly SM. Interatrial shunt devices for the treatment of heart failure. Trends in Cardiovascular Medicine 2020. [DOI: 10.1016/j.tcm.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Bakhshaliyev N, Çelikkale İ, Enhoş A, Karaçöp E, Uluganyan M, Özdemir R. Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure : Insights from a single site in the PRELIEVE study. Herz 2021. [PMID: 34459929 DOI: 10.1007/s00059-021-05063-w] [Reference Citation Analysis]
2 Andersen A, Andersen MJ. Editorial commentary: Elevated left atrial pressure in heart failure: should you relieve the pressure? Trends Cardiovasc Med 2021;31:433-4. [PMID: 33129972 DOI: 10.1016/j.tcm.2020.10.008] [Reference Citation Analysis]
3 Piccinelli E, Castro-Verdes MB, Fraisse A, Bautista-Rodriguez C. Implantation of an Atrial Flow Regulator in a Child on Venoarterial Extracorporeal Membrane Oxygenator as a Bridge to Heart Transplant: A Case Report. J Card Fail 2021;27:364-7. [PMID: 33242607 DOI: 10.1016/j.cardfail.2020.11.006] [Reference Citation Analysis]
4 Das BB. Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future. Paediatr Drugs 2022;24:235-46. [PMID: 35501560 DOI: 10.1007/s40272-022-00508-z] [Reference Citation Analysis]